54 related articles for article (PubMed ID: 31006218)
1. [Feasibility and safety of MRgFUS ablation for uterine fibroids and adenomyosis: a preliminary study].
Huang YQ; Zhou SG; Wang J; Deng LX; Li ZW; Xu YH
Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1152-1155. PubMed ID: 31006218
[No Abstract] [Full Text] [Related]
2. Diffusion-weighted imaging as a potential non-gadolinium alternative for immediate assessing the hyperacute outcome of MRgFUS ablation for uterine fibroids.
Huang Y; Zhou S; Su Y; Pang Z; Cai S
Sci Rep; 2024 Apr; 14(1):9857. PubMed ID: 38684835
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids.
O'Sullivan AK; Thompson D; Chu P; Lee DW; Stewart EA; Weinstein MC
Int J Technol Assess Health Care; 2009 Jan; 25(1):14-25. PubMed ID: 19126247
[TBL] [Abstract][Full Text] [Related]
4. Optimized treatment parameter by computer simulation for high-intensity focused ultrasound treatment of uterine adenomyosis: Short-term and long-term results.
Bae JS; Lee JY; Chung HH; Lee M; Jeon MJ; Kim H; Kim HS; Kim K; Lee CS; Son K; Han JK
PLoS One; 2024; 19(3):e0301193. PubMed ID: 38547090
[TBL] [Abstract][Full Text] [Related]
5. [Preoperative MR T
Yu J; Yang M; Jiang L; Xiao Z; Li S; Chen J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):597-603. PubMed ID: 37202196
[TBL] [Abstract][Full Text] [Related]
6. Transcervical Ultrasound-guided Radiofrequency Ablation of Adenomyosis: A Case Report.
Goldrath KE; Parvataneni R; Munro MG; Mehta SK
J Minim Invasive Gynecol; 2023 Jun; 30(6):502-507. PubMed ID: 36878403
[TBL] [Abstract][Full Text] [Related]
7. Non-contrast enhanced MRI for efficiency evaluation of high-intensity focused ultrasound in adenomyosis ablation.
Si M; Lv F; Tang M; Liu Y; Qiu X; Gong C; Hu Y; Liu Y
Int J Hyperthermia; 2024; 41(1):2295813. PubMed ID: 38234000
[TBL] [Abstract][Full Text] [Related]
8. Long-term re-intervention after USgHIFU and prediction of NPVR in different ages of patients with uterine fibroids.
Li S; Ma WW; Yang MJ; Deng YB; Hu L; Chen JY
Int J Hyperthermia; 2024; 41(1):2304264. PubMed ID: 38258583
[TBL] [Abstract][Full Text] [Related]
9. Editorial for "Magnetic Resonance Imaging-Based Classification Systems for Informing Better Outcomes of Adenomyosis After Ultrasound-Guided High-Intensity Focused Ultrasound Ablating Surgery".
Bucher AM; Penzkofer T; May MS
J Magn Reson Imaging; 2024 May; 59(5):1798-1799. PubMed ID: 37702415
[No Abstract] [Full Text] [Related]
10. Cystic Adenomyosis in a Subserosal Fibroid.
Marien M; Zeni G; Tigdi J; Al-Salem H; Leonardi M
J Obstet Gynaecol Can; 2023 Nov; 45(11):101921. PubMed ID: 35276428
[No Abstract] [Full Text] [Related]
11. Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy.
Taran FA; Stewart EA; Brucker S
Geburtshilfe Frauenheilkd; 2013 Sep; 73(9):924-931. PubMed ID: 24771944
[TBL] [Abstract][Full Text] [Related]
12. Biomechanical testing of ex vivo porcine tendons following high intensity focused ultrasound thermal ablation.
Chu Kwan W; Partanen A; Narayanan U; Waspe AC; Drake JM
PLoS One; 2024; 19(5):e0302778. PubMed ID: 38713687
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive magnetic resonance-guided focused ultrasound for tendon disruption: an
Chu Kwan W; den Otter-Moore I; Partanen A; Piorkowska K; Waspe AC; Drake JM
Int J Hyperthermia; 2023; 40(1):2260129. PubMed ID: 37743063
[TBL] [Abstract][Full Text] [Related]
14. I saw the Venetian blind sign.
Heil S; Nasrullah A
Clin Imaging; 2024 Feb; 106():110050. PubMed ID: 38118286
[TBL] [Abstract][Full Text] [Related]
15. Knowledge, attitudes, and practices among Chinese reproductive-age women toward uterine adenomyosis.
Ren R; Li H; Zhang J; Li X; Yuan L; Li D; Shan S; Shi B; Jiang J
Front Med (Lausanne); 2024; 11():1361671. PubMed ID: 38651069
[TBL] [Abstract][Full Text] [Related]
16. Complications of transvaginal radiofrequency ablation of fibroids: A 5-year experience.
Santalla-Hernández A; Naveiro-Fuentes M; Benito-Villena R; Villegas-Alcazar J; López-Criado MS; Lara-Serrano A; Parra JF; Alcázar JL; Pelayo-Delgado I
Eur J Obstet Gynecol Reprod Biol X; 2023 Dec; 20():100244. PubMed ID: 37869066
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Ultrasound-Guided High-Intensity Focused Ultrasound Treatment for Uterine Fibroids and Adenomyosis.
Lee JS; Hong GY; Lee KH; Song JH; Kim TE
Ultrasound Med Biol; 2019 Dec; 45(12):3214-3221. PubMed ID: 31563479
[TBL] [Abstract][Full Text] [Related]
18. MR-guided focused ultrasound surgery: A novel non-invasive technique in the treatment of adenomyosis -18 month's follow-up of 12 cases.
Dev B; Gadddam S; Kumar M; Varadarajan S
Indian J Radiol Imaging; 2019; 29(3):284-288. PubMed ID: 31741597
[TBL] [Abstract][Full Text] [Related]
19. A Prediction of NPVR ≥ 80% of Ultrasound-Guided High-Intensity Focused Ultrasound Ablation for Uterine Fibroids.
Yang MJ; Yu RQ; Chen WZ; Chen JY; Wang ZB
Front Surg; 2021; 8():663128. PubMed ID: 34150838
[No Abstract] [Full Text] [Related]
20. Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: A systematic review and meta-analysis.
Verpalen IM; Anneveldt KJ; Nijholt IM; Schutte JM; Dijkstra JR; Franx A; Bartels LW; Moonen CTW; Edens MA; Boomsma MF
Eur J Radiol; 2019 Nov; 120():108700. PubMed ID: 31634683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
